Your browser doesn't support javascript.
loading
HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
Dong, Shanshan; Wang, Ranran; Wang, Hui; Ding, Qi; Zhou, Xiao; Wang, Jing; Zhang, Keqiang; Long, Ying; Lu, Shan; Hong, Ting; Ren, Huayi; Wong, Kee; Sheng, Xiaowu; Wang, Yu; Zeng, Yong.
Afiliação
  • Dong S; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Wang R; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
  • Wang H; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Ding Q; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
  • Zhou X; Key Laboratory of Radiation Oncology, Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
  • Wang J; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Zhang K; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
  • Long Y; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Lu S; Engineering Technology Research Center for diagnosis-treatment and application of tumor liquid biopsy, Changsha, China.
  • Hong T; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Ren H; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Wong K; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Sheng X; Department of Biochemistry and Molecular Biology, Second Military Medical University, Changsha, China.
  • Wang Y; The fifth department of gynecological oncology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Zeng Y; Translational Medicine Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
J Exp Clin Cancer Res ; 38(1): 110, 2019 Mar 01.
Article em En | MEDLINE | ID: mdl-30823895
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Fosfatidilinositol 3-Quinases / MicroRNAs / Transição Epitelial-Mesenquimal / RNA Longo não Codificante / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Fosfatidilinositol 3-Quinases / MicroRNAs / Transição Epitelial-Mesenquimal / RNA Longo não Codificante / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article